Rankings
▼
Calendar
INGN Q2 2024 Earnings — Inogen, Inc. Revenue & Financial Results | Market Cap Arena
INGN
Inogen, Inc.
$171M
Q2 2024 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$89M
+6.1% YoY
Gross Profit
$43M
48.1% margin
Operating Income
-$7M
-8.0% margin
Net Income
-$6M
-6.3% margin
EPS (Diluted)
$-0.24
QoQ Revenue Growth
+13.8%
Cash Flow
Operating Cash Flow
$7M
Free Cash Flow
$2M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$309M
Total Liabilities
$121M
Stockholders' Equity
$188M
Cash & Equivalents
$98M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$89M
$84M
+6.1%
Gross Profit
$43M
$34M
+25.5%
Operating Income
-$7M
-$12M
+40.0%
Net Income
-$6M
-$10M
+43.1%
Geographic Segments
UNITED STATES
$58M
66%
Non-US
$31M
34%
← FY 2024
All Quarters
Q3 2024 →